{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:28Z","timestamp":1761513928302},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["QJM"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1093\/qjmed\/hcw206","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T04:54:24Z","timestamp":1482555264000},"page":"53-54","source":"Crossref","is-referenced-by-count":6,"title":["Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia"],"prefix":"10.1093","volume":"110","author":[{"given":"A.","family":"Fountas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tsatsoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"2017012307550802000_110.1.53.1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcu166"},{"key":"2017012307550802000_110.1.53.2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcw013"},{"key":"2017012307550802000_110.1.53.3","doi-asserted-by":"publisher","DOI":"10.4158\/EP14410.OR"},{"key":"2017012307550802000_110.1.53.4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2013.03.034","article-title":"Denosumab in breast cancer treatment","volume":"717","author":"Drooger","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"2017012307550802000_110.1.53.5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.12188","article-title":"Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis","volume":"79","author":"Makras","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2017012307550802000_110.1.53.6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12902-015-0077-3","article-title":"Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study","volume":"15","author":"Nakamura","year":"2015","journal-title":"BMC Endocr Disord"}],"container-title":["QJM"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/110\/1\/53\/9692688\/hcw206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T20:19:55Z","timestamp":1503605995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article-lookup\/doi\/10.1093\/qjmed\/hcw206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,23]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1093\/qjmed\/hcw206"],"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcw206","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]}}}